« Back to news listing

Knobbe Martens Client Ulthera Expands Its Aesthetics Technology Portfolio

Knobbe Martens client Ulthera, Inc., a global medical device company focused on developing and commercializing technologies for aesthetic and medical applications, announced on March 21, 2014 that it has acquired Cabochon Aesthetics, Inc., the ninth company started by premier medical device incubator, The Foundry.  The FDA-cleared system developed by Cabochon — used in a procedure to improve the appearance of cellulite — will allow Ulthera to expand its technology offerings for physician practices worldwide.   Ulthera’s signature technology is the Ulthera® System, which is the first and only energy-based device that is FDA-cleared for use as an aesthetic treatment — the Ultherapy® procedure — that non-invasively lifts the eyebrow and skin on the neck and under the chin.   Knobbe Martens Orange County partners, Dr. Salima Merani and Terry Tullis, who have represented Ulthera for several years, represented the company in the acquisition of Cabochon with respect to intellectual property matters.

« Back to news listing